Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-09-029524
Filing Date
2009-08-04
Accepted
2009-08-04 15:24:58
Documents
2
Group Members
ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 2004 BVIII LLCMPM BIOVENTURES III GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES III GP, L.P.MPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND, L.P.MPM BIO

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D f53158sc13dza.htm SC 13D/A 280164
2 EX-99.1 f53158exv99w1.htm EX-99.1 22773
  Complete submission text file 0000950123-09-029524.txt   305610
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III LP (Filed by) CIK: 0001173408 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Subject) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80900 | Film No.: 09983388
SIC: 2834 Pharmaceutical Preparations